Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00493350 · ClinicalTrials.gov registry record
Prospective Validation Trial of Circulating Tumor Cells (CTCs) in Women With Metastatic Breast Cancer
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 660
- Enrollment target
NCT00493350: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00493350 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 660 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00493350 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 660 participants
- Enrollment target
Study Summary
Primary Objectives: 1. To validate the prognostic significance of circulating tumor cells (CTCs) in patients with newly diagnosed metastatic breast cancer (MBC). 2. To prospectively determine if assessment of CTCs can be used to stratify patients with MBC into two prognostic groups independent of existing methods i.e. hormone-receptor status, site of metastasis (e.g. visceral vs. non visceral) and treatment administered (e.g. chemotherapy vs. hormonal therapy). 3. To incorporate this information into the current TNM staging system by sub-classifying stage IV disease into two prognostic groups, Stage IVA and Stage IVB. Secondary Objective: 1\. To perform global gene profiling on selected specimens and correlate the profiles with clinical outcomes.
Interventions
- PROCEDURE Blood Sample
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 660 participants |
| Start Date | 2005-10 |
| Est. Completion | 2007-12 |
What the finished NCT00493350 record still lists
NCT00493350 is an observational study that tracks outcomes without assigning an intervention. The registered 660 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Blood Sample is the first listed.
NCT00493350 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00493350 about?
NCT00493350 is a clinical study titled "Prospective Validation Trial of Circulating Tumor Cells (CTCs) in Women With Metastatic Breast Cancer". Primary Objectives: 1. To validate the prognostic significance of circulating tumor cells (CTCs) in patients with newly diagnosed metastatic breast cancer (MBC). 2. To prospectively determine if assessment of CTCs can be used to stratify patients with MBC into two prognostic groups independent of e...
What is the current status of trial NCT00493350?
This trial is currently completed. The enrollment target is 660 participants. The study started on 2005-10. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00493350?
The interventions under investigation include: Blood Sample (PROCEDURE).
Who is sponsoring clinical trial NCT00493350?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01185132 · 660 participants · Phase 3
Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy
- NCT03346694 · 660 participants · NA
Reducing Surgical Site Infection Rates Using an Alternative Sternal Dressing
- NCT05407636 · 660 participants · Phase 3
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
- NCT05470205 · 660 participants · Phase 3
Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia